84
https://pubmed.ncbi.nlm.nih.gov/38117798
This study reveals that analyzing the “dark genome” could offer promising prospects for cancer treatment, as dark genes exhibit high mutation rates in certain cancers and influence patient survival outcomes, similar to light genes.